Abstract
Crataegus sp., also known as “hawthorn”, is one of the most prescribed herbal drugs and approved to be used against congestive heart failure. The extract is required to be standardized according to its flavonoid (vitexine-2″-O-rhamnoside and hyperoside) and oligomeric procyanidin content by the European Pharmacopoeia (EP). In this study, the leaves and berries of three Crataegus species including C. aronia var. aronia, C. monogyna ssp. monogyna (from two different localities) as well as C. pseudoheterophylla growing in Turkey were evaluated for their vitexine-2″-O-rhamnoside and hyperoside content by reversed-phase HPLC as well as their total procyanidin amount by a spectrophotometric method. In addition, antibacterial, antifungal, and antiviral activities of the extracts were also determined. Our results indicated that C. monogyna ssp. monogyna samples of both localities met the criteria required by the EP for their total flavonoid amount (2.49 and 2.86%) and total proanthocyanidin content (1.56 and 2.22%). According to data we obtained, the extracts have been verified to be highly effective against Candida albicans and Herpes simplex virus.
Similar content being viewed by others
References
Holubarsch CJF, Colucci WS, Meinertz T, Gaus W, Tendera M (2000) Eur J Heart Fail 2:431–437
Zapfe G (2001) Phytomed 8:262–266
Valli G, Giardina EGV (2002) J Am Coll Cardiol 39:1083–1095
Degengring FH, Suter A, Weber M, Saller R (2003) Phytomed 10:363–369
Schröder D, Weiser M, Klein P (2003) Eur J Heart Fail 5:319–326
Kroll M, Ring C, Gaus W, Hempel B (2005) Phytomed 12:395–402
Davis PH, Cullen J (1984) Crataegus In: Davis PH (ed) Flora of Turkey and the East Aegean Islands, vol.1. Edinburgh University Press, Edinburgh
American Herbal PharmacopoeiaTM and Therapeutic Compendium (1999) In: Upton R (ed). AHP Press, Santa Cruz
Hiermann A, Karting T, Azzam S (1986) Sci Pharm 54:331–337
National Committee for Clinical Laboratory Standards (1996), Method for broth dilution antifungal susceptibility testing yeast; approved standard, M27-A, 15, 10. NCCLS, Tucson, AZ, USA
National Committee for Clinical Laboratory Standards (2002), Methods for dilution antimicrobial susceptibility tests bacteria that grow aerobically, 3rd edn, approved standard. NCCLS document M100-S12. NCCLS, Wayne, PA, USA
Özçelik B, Aslan M, Orhan I, Karaoglu T (2005) Microbiol Res 160:159–164
Güven K, Yücel E, Çetintaş F (2006) Pharm Biol 44:79–83
Min BS, Bae KH, Kim YH, Miyashiro H, Hattori M, Shimotohno K (1999) Phytother Res 13:680–682
Min BS, Jung HJ, Lee JS, Kim YH, BOK SH, Ma CM, Nakamura N, Hattori M, Bae K (1999) Planta Med 65:374–375
Shahat AA, Cos P, De Bruyne T, Apers S, Hammouda FM., Ismail SI, Azzam S, Claeys M, Goovaerts E, Pieters L, Van den Berghe D, Vlietinck AJ (2002) Planta Med 68:539–541
Shahat AA, Ismail SI, Hammouda FM, Azzam SA, Lemie`re G, De Bruyne T, De Swaef S, Pieters L, Vlietinck A (1998) Phytomed 5:133–136
Author information
Authors and Affiliations
Corresponding author
Additional information
Application of Separation Techniques in Turkey.
Rights and permissions
About this article
Cite this article
Orhan, I., Özçelik, B., Kartal, M. et al. HPLC Quantification of Vitexine-2″-O-rhamnoside and Hyperoside in Three Crataegus Species and Their Antimicrobial and Antiviral Activities. Chroma 66 (Suppl 1), 153–157 (2007). https://doi.org/10.1365/s10337-007-0283-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-007-0283-x